These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6128633)

  • 21. Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis.
    Skoczynska A; Ruckly C; Hong E; Taha MK
    Clin Microbiol Infect; 2009 Dec; 15(12):1178-81. PubMed ID: 19456827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Meningococcal infection in London.
    Emond RT; Smith H
    Lancet; 1974 Nov; 2(7888):1076. PubMed ID: 4138344
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidemiology and prevention of meningococcal disease.
    Riedo FX; Plikaytis BD; Broome CV
    Pediatr Infect Dis J; 1995 Aug; 14(8):643-57. PubMed ID: 8532420
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 25. Meningococcaemia: current concepts in prophylaxis.
    Ball AP
    J Infect; 1980 Dec; 2(4):316-9. PubMed ID: 6821087
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Chemoprophylaxis of meningococcal infections.
    Lancet; 1974 Dec; 2(7894):1431-2. PubMed ID: 4140338
    [No Abstract]   [Full Text] [Related]  

  • 27. Meningococcal vaccination and Hajj pilgrimage.
    Rashid H; Khatami A; Haworth E; Booy R
    Lancet; 2015 Mar; 385(9973):1072-3. PubMed ID: 25797556
    [No Abstract]   [Full Text] [Related]  

  • 28. Meningococcal carriage: the dilemma of 4CMenB vaccine.
    Taha MK; Deghmane AE
    Lancet; 2014 Dec; 384(9960):2088-90. PubMed ID: 25145776
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of rifampin on the carrier state of Neisseria meningitidis and drug-sensitivity test (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Nov; 15(6):371-2. PubMed ID: 6806022
    [No Abstract]   [Full Text] [Related]  

  • 30. In brief: Meningococcal prophylaxis.
    Med Lett Drugs Ther; 2008 Apr; 50(1283):25. PubMed ID: 18391897
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of coumermycin A on the meningococcal carrier state.
    Devine LF; Johnson DP; Hagerman CR; Pierce WE; Rhode SL; Peckinpaugh RO
    Am J Med Sci; 1970 Sep; 260(3):165-70. PubMed ID: 4991431
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the sanative action of rifampicin on the meningococcal carrier state].
    Deviatkina NP; Demina AA; Orlova EV; Timina VP; Petrova IS
    Antibiotiki; 1978 Sep; 23(9):794-7. PubMed ID: 100048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province].
    Ercis S; Köseoğlu O; Salmanzadeh-Ahrabi S; Ercis M; Akin L; Hasçelik C
    Mikrobiyol Bul; 2005 Oct; 39(4):411-20. PubMed ID: 16544542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.
    Schwartz B; Al-Tobaiqi A; Al-Ruwais A; Fontaine RE; A'ashi J; Hightower AW; Broome CV; Music SI
    Lancet; 1988 Jun; 1(8597):1239-42. PubMed ID: 2897515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Are environmental studies useful in meningococcal infections?].
    Berger U
    Munch Med Wochenschr; 1968 Mar; 110(12):714-7. PubMed ID: 4970727
    [No Abstract]   [Full Text] [Related]  

  • 36. Rifampin-resistant meningococcal disease.
    Rainbow J; Cebelinski E; Bartkus J; Glennen A; Boxrud D; Lynfield R
    Emerg Infect Dis; 2005 Jun; 11(6):977-9. PubMed ID: 15963302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of gonococci and meningococci in vitro to rifampin (rifampicin) resistance.
    Schneider H; Dobek AS; Artenstein MS
    Br J Vener Dis; 1972 Dec; 48(6):500-3. PubMed ID: 4631230
    [No Abstract]   [Full Text] [Related]  

  • 38. [Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
    Carabias ML; Cervera LA; García-Navas BL; entelles ML
    Rev Esp Quimioter; 2001 Jun; 14(2):177-83. PubMed ID: 11704772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the in-vitro sensitivity of meningococci and its implications in prophylaxis.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Acta Clin Belg; 1973; 28(5):281-6. PubMed ID: 4204781
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
    Delia S; Mauro A; Miceli MT
    Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.